Canadian Cardiovascular Society Awarded $1.4M to Continue Important National Study of COVID-19 and mRNA Vaccines
June 7, 2024
New funding from the Public Health Agency of Canada (PHAC) will enable top Canadian cardiology...
CCS News COVID-19 MYCOVACC
Canadian Cardiovascular Society Awarded $1.4M to Continue Important National Study of COVID-19 and mRNA Vaccines
June 7, 2024
New funding from the Public Health Agency of Canada (PHAC) will enable top Canadian cardiology...
CCS News COVID-19 MYCOVACC Canadian Cardiovascular Society receives $2M to expand study of COVID-19 mRNA vaccines
June 21, 2023
With new funding, major pan-Canadian initiative broadens its scope and extends follow-up of...
CCS News COVID-19 MYCOVACCCall to Action: Contribute to the CCS Vaccine-Associated Myocarditis Study
December 22, 2022
The CCS is actively recruiting cardiac care centres, cardiology clinics and cardiologists from...
MYCOVACCCanadian Cardiovascular Society Receives $1.6 million to Study Myocarditis and/or Pericarditis after mRNA COVID-19 Vaccination
October 27, 2022
Today, at the Canadian Cardiovascular Congress where more than 1200 cardiovascular specialists and...
MYCOVACC